Critic At Large Articles - science publishing, techniques and disease/medicine

By Bonnie M. Marshall and Stuart B. Levy | April 1, 2012

Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.

By Richard P. Sloan | August 1, 2011

Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.

By Robert E. Schenter | July 1, 2011

New strategies are needed to address the current and future shortages of radioisotopes that threaten medical research and treatment.

By Michael K. Gusmano | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

By Nicholas P. Restifo and Megan Bachinski | April 11, 2011

For cancer patients, close is not good enough.

By H. Steven Wiley | February 1, 2011

Data standards need to be introduced—now.

By Rob Carlson | January 1, 2011

The potential costs of regulating synthetic biology must be counted against putative benefits.

The Scientist